Daun02
CAS No. 290304-24-4
Daun02 ( Daun 02;Daun-02 )
Catalog No. M13892 CAS No. 290304-24-4
Daun02 a prodrug that is converted by β-galactosidase to Daunorubicin, inactivate activated neurons that express both β-galactosidase and Fos.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 672 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDaun02
-
NoteResearch use only, not for human use.
-
Brief DescriptionDaun02 a prodrug that is converted by β-galactosidase to Daunorubicin, inactivate activated neurons that express both β-galactosidase and Fos.
-
DescriptionDaun02 a prodrug that is converted by β-galactosidase to Daunorubicin, inactivate activated neurons that express both β-galactosidase and Fos, specifically attenuates cocaine-induced locomotor activity, also attenuates cocaine-induced β-galactosidase expression; daunorubicin, the active product of Daun02 metabolism by β-galactosidase, decreases the activity of MSNs in rat brain slices and that Daun02 strongly decreases the excitability of rat MSN primary cultures expressing β-galactosidase upon D1 dopamine receptor stimulation; Daun02-inactivation method, selectively inactivate only those neurons activated by cocaine in an environment repeatedly paired with drug injections.
-
SynonymsDaun 02;Daun-02
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADC Cytotoxin
-
RecptorADC Cytotoxin
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number290304-24-4
-
Formula Weight884.79
-
Molecular FormulaC41H44N2O20
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(OCC1=CC=C(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)C([N+]([O-])=O)=C1)N[C@@H]3[C@H](O)[C@H](C)O[C@@H](OC4CC(O)(C(C)=O)CC5=C(O)C6=C(C(C7=C(OC)C=CC=C7C6=O)=O)C(O)=C45)C3
-
Chemical Name(1R,2R,6S,18R,20S)-3-nitro-4-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)benzyl (2S,3S,4S,6R)-6-(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yloxy)-3-hydroxy-2-methyl-tetrahydro-2H
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Koya E, et al. Nat Neurosci. 2009 Aug;12(8):1069-73.
2. Farquhar D, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70.
3. Koya E, et al. Curr Protoc Neurosci. 2016 Jul 1;76:8.36.1-8.36.17.
4. Cruz FC, et al. J Neurosci. 2014 May 28;34(22):7437-46.
2. Farquhar D, et al. Cancer Chemother Pharmacol. 2002 Jul;50(1):65-70.
3. Koya E, et al. Curr Protoc Neurosci. 2016 Jul 1;76:8.36.1-8.36.17.
4. Cruz FC, et al. J Neurosci. 2014 May 28;34(22):7437-46.
molnova catalog
related products
-
PNU-159682
A highly potent metabolite of the anthracycline nemorubicin with outstanding cytotoxicity; a topoisomerase inhibitor and ADCs cytotoxin.
-
MMAF-OMe
An antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin.
-
SG3199
SG3199 (SG-3199) is a PBD dimer warhead component of antibody-drug conjugate (ADC) payload tesirine, demonstrates potently cytotoxic against a panel of human solid tumour and haematological cancer cell lines with mean GI50 of 151.5 pM.